Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this memorable scientific session on the management of venous thromboembolism in patients of general surgery.
Venous thromboembolism is the most common cause of death observed in surgical patients. The risk of venous thromboembolism (VTE) among the population of postoperative patients is heterogeneous and depends on intrinsic patient factors.
The risk is determined by the combination of different factors and features such as the use of prophylaxis, perioperative care, etc which are related to the type of surgery. It is evident that extended use of prophylaxis, early mobilization, and the implication of improved perioperative care can help in reducing the risk of VTE in surgical patients.
Thus, depending on the risk for VTE and major bleeding in surgical patients combined methods of mechanical and pharmacological prophylaxis or only mechanical prophylaxis may be preferred.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Does pollution cause cancer?
2.
AI is equally capable of reading breast cancer scans as human radiologists.
3.
EVP Beats Cisplatin for Resectable MIBC
4.
New research points out a promising strategy for treating metastatic medulloblastoma
5.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection
3.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
4.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
5.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
5.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation